Derivatives of pyridoxine for inhibiting HIV integrase
US8664248B2 · kind B2 · utility
0Cited by
36References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2012 |
| Grant date | Mar 4, 2014 |
| Priority date | — |
| Expiry date | Sep 6, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating hepatitis C infection, HIV infection, AIDS, or AIDS-related complex, or inhibiting HIV replication by administering a compound of Formula I or pharmaceutically acceptable salts thereof, to a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.